Vista Pharmaceuticals share news, announcements and annual reports
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹6.45.
30 Oct: open ₹6.50, high ₹6.50, low ₹6.15
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹38 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,884
Vista Pharmaceuticals share news and announcements
532 announcements, routine notices left out, newest first. Page 2 of 11.
Nov 2024
7 Nov · Board meeting
Meeting on 13 Nov 2024: quarterly results
Sep 2024
30 Sep · Meeting
30 Sep · Meeting
8 Sep · Meeting
Aug 2024
14 Aug · Business
13 Aug · Board meeting
5 Aug · Board meeting
Meeting on 13 Aug 2024: quarterly results
Jun 2024
14 Jun · Announcement under Regulation 30 (LODR)-Allotment
May 2024
28 May · Board meeting
21 May · Board meeting
Meeting on 28 May 2024: audited results
Apr 2024
30 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
30 Apr · Compliance Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
30 Apr · Compliance As Per Regulation 40 (10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31.03.2024
Feb 2024
13 Feb · Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 13.02.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
10 Feb · Management
10 Feb · Board meeting
2 Feb · Board meeting
Meeting on 10 Feb 2024: quarterly results
Jan 2024
29 Jan · Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 29.01.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
8 Jan · Announcement under Regulation 30 (LODR)-Allotment
Dec 2023
30 Dec · Announcement under Regulation 30 (LODR)-Allotment
6 Dec · Announcement under Regulation 30 (LODR)-Allotment
Nov 2023
28 Nov · Announcement under Regulation 30 (LODR)-Allotment
7 Nov · Announcement under Regulation 30 (LODR)-Allotment
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Oct 2023
20 Oct · Announcement under Regulation 30 (LODR)-Allotment
16 Oct · Announcement under Regulation 30 (LODR)-Allotment
9 Oct · Announcement under Regulation 30 (LODR)-Allotment
Sep 2023
20 Sep · Announcement under Regulation 30 (LODR)-Allotment
7 Sep · Meeting
6 Sep · Board meeting
1 Sep · Board meeting
Meeting on 6 Sep 2023: annual general meeting, preferential issue of shares and increase in authorised capital
Aug 2023
26 Aug · Announcement under Regulation 30 (LODR)-Allotment
12 Aug · Results
7 Aug · Board meeting
Meeting on 12 Aug 2023: quarterly results